OXIDOPAMINE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease). (Chemical Entities of Biological Interest Ontology, CHEBI_78741)
External Link https://dgidb.org/results?searchType=drug&searchTerms=OXIDOPAMINE
Similar Terms
Downloads & Tools

Genes

20 interacting proteins for the OXIDOPAMINE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
HPD 4-hydroxyphenylpyruvate dioxygenase 3.5288
SYP synaptophysin 2.35253
SOAT1 sterol O-acyltransferase 1 0.6416
KCNA2 potassium channel, voltage gated shaker related subfamily A, member 2 0.6416
ITGAM integrin, alpha M (complement component 3 receptor 3 subunit) 0.588133
GNRH1 gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) 0.392089
LPL lipoprotein lipase 0.22055
FAAH fatty acid amide hydrolase 0.185726
GRIA4 glutamate receptor, ionotropic, AMPA 4 0.185726
MAPK9 mitogen-activated protein kinase 9 0.172137
DDIT3 DNA-damage-inducible transcript 3 0.172137
MAPK10 mitogen-activated protein kinase 10 0.135723
THRB thyroid hormone receptor, beta 0.0989383
BDNF brain-derived neurotrophic factor 0.0665811
RECQL RecQ helicase-like 0.0608414
APEX1 APEX nuclease (multifunctional DNA repair enzyme) 1 0.0591419
POLK polymerase (DNA directed) kappa 0.0401
PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 0.0379441
DRD2 dopamine receptor D2 0.031791
VDR vitamin D (1,25- dihydroxyvitamin D3) receptor 0.0216934